Pages that link to "Q35243711"

The following pages link to Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution method (Q35243711):

Displaying 34 items.

• A random sequencing approach for placing markers on the physical map of Mycoplasma genitalium (Q24629058) (← links)
• Susceptibilities of Mycoplasma hominis and Ureaplasma urealyticum to two new quinolones, sparfloxacin and WIN 57273 (Q28333684) (← links)
• Practical recommendations for the drug treatment of bacterial infections of the male genital tract including urethritis, epididymitis and prostatitis. (Q33649654) (← links)
• In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391. (Q33744065) (← links)
• Sparfloxacin selects gyrase mutations in first-step Mycoplasma hominis mutants, whereas ofloxacin selects topoisomerase IV mutations. (Q33977877) (← links)
• Comparative in vitro susceptibilities and bactericidal activities of investigational fluoroquinolone ABT-492 and other antimicrobial agents against human mycoplasmas and ureaplasmas (Q34230978) (← links)
• Fleroxacin. A review of its pharmacology and therapeutic efficacy in various infections (Q34299063) (← links)
• Hematoma and abscess formation caused by Mycoplasma hominis following cesarean section (Q34574124) (← links)
• In vitro susceptibilities to and bactericidal activities of garenoxacin (BMS-284756) and other antimicrobial agents against human mycoplasmas and ureaplasmas (Q34722677) (← links)
• In vitro antibiotic susceptibility testing of clinical isolates of Mycoplasma penetrans from patients with AIDS. (Q35115649) (← links)
• Increase in resistance of Mycoplasma hominis to tetracyclines (Q35284107) (← links)
• In vitro antimycoplasmal activities of rufloxacin and its metabolite MF 922. (Q35822578) (← links)
• In vitro antibiotic susceptibility testing of different strains of Mycoplasma fermentans isolated from a variety of sources (Q35900393) (← links)
• Fleroxacin clinical pharmacokinetics (Q35932150) (← links)
• In vitro susceptibility of Ureaplasma urealyticum and Mycoplasma hominis isolates in Argentina (Q36624949) (← links)
• Newly documented antimicrobial activity of quinolones (Q37222571) (← links)
• A review of the antimicrobial activity of the fluoroquinolones. (Q37834318) (← links)
• The effect of ciprofloxacin and doxycycline plus metronidazole on lower genital tract flora in patients with proven pelvic inflammatory disease (Q37895549) (← links)
• In vitro susceptibilities of Mycoplasma hominis to six fluoroquinolones as determined by E test. (Q39472088) (← links)
• Susceptibilities of Mycoplasma hominis, M. pneumoniae, and Ureaplasma urealyticum to GAR-936, dalfopristin, dirithromycin, evernimicin, gatifloxacin, linezolid, moxifloxacin, quinupristin-dalfopristin, and telithromycin compared to their susceptibil (Q39478313) (← links)
• Susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to a new quinolone, trovafloxacin (CP-99,219). (Q39781930) (← links)
• Intraprostatic distribution of lomefloxacin following multiple-dose administration (Q39817359) (← links)
• Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to a new quinolone, OPC 17116. (Q39866485) (← links)
• Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines (Q39867257) (← links)
• Susceptibility of Mycoplasma pneumoniae to several new quinolones, tetracycline, and erythromycin (Q40086180) (← links)
• Major advances in antibacterial quinolone therapy (Q40573690) (← links)
• Pharmacokinetics of difloxacin in olive flounder Paralichthys olivaceus at two water temperatures (Q42602439) (← links)
• Permeability and concentration of levofloxacin in epithelial lining fluid in patients with lower respiratory tract infections (Q43207762) (← links)
• Lomefloxacin: Microbiologic assessment and unique properties (Q43407841) (← links)
• Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum (Q44040319) (← links)
• Chemical constituents of Euonymus fortunei. (Q53250459) (← links)
• In vitro susceptibility of tetracycline-resistant strains of Ureaplasma urealyticum to newer macrolides and quinolones, and a streptogramin (Q67864177) (← links)
• Fluoroquinolone antimicrobial agents (Q69548929) (← links)
• Pharmacokinetic properties and oral bioavailabilities of difloxacin in pig and chicken (Q77386700) (← links)